Original articleAmniocentesis or chorionic villus sampling for prenatal genetic testing: A decision analysis
References (77)
- et al.
Anxiety reduction after chorionic villus sampling and genetic amniocentesis
Am J Obstet Gynecol
(1988) - et al.
Chorionic villus sampling: experience in the first 1000 cases
Am J Obstet Gynecol
(1986) - et al.
Spontaneous abortion in proven intact pregnancies
Lancet
(1984) - et al.
Spontaneous fetal loss in early pregnancy
Lancet
(1985) - et al.
Midtrimester amniocenteses: an analysis of 923 cases with neonatal follow-up
Am J Obstet Gynecol
(1983) - et al.
Analysis of 2136 genetic amniocentesis: experience of a single physician
Am J Obstet Gynecol
(1985) - et al.
Randomized controlled trial of genetic amniocentesis in 4606 low-risk women
Lancet
(1986) - et al.
The results of one thousand consecutive prenatal diagnoses
Am J Obstet Gynecol
(1983) - et al.
Chorionic villus sampling in continuing pregnancies. II. Cytogenetic reliability
Am J Obstet Gynecol
(1986) Bayes' theorem and conditional nonindependence of data in medical diagnosis
Comp Biomed Res
(1978)
Utility approach to measuring health-related quality of life
J Chron Dis
Construction of social value or utility-based health indices: the usefulness of factorial experimental design plans
J Chron Dis
Social preferences for health states: an empirical evaluation of three measurement techniques
Socioecon Planning Sci
Acceptability of chorionic villi sampling for prenatal diagnosis
Am J Obstet Gynecol
Chromosomal abnormality rates at amniocentesis and in live born infants
JAMA
Midtrimester amniocentesis for prenatal diagnosis: safety and accuracy
JAMA
A comparison of chorionic villi sampling and amniocentesis: acceptability of procedure and maternal attachment to pregnancy
Obstet Gynecol
The safety and efficacy of chorionic villus sampling for early prenatal diagnosis
N Engl J Med
Extra embryonic/fetal karyotypic discordance during diagnostic chorionic villus sampling
Prenat Diagn
Decision analysis
N Engl J Med
Decision analysis: a progress report
Ann Intern Med
Complications of first-trimester abortion: a report of 170,000 cases
Obstet Gynecol
Low fetal loss rates after ultrasound-proved viability in early pregnancy
JAMA
Spontaneous abortion and pregnancy outcome after normal first-trimester ultrasound examination
Obstet Gynecol
Spontaneous fetal loss after demonstration of a live fetus in the first trimester
Obstet Gynecol
Spontaneous abortion rate in ultrasonographically viable pregnancies
Obstet Gynecol
A prospective study of spontaneous miscarriage in ultrasonographically normal pregnancies and relevance to chorionic villus sampling
Prenat Diagn
Sixteen years' experience in counseling, diagnosis and prenatal detection in one genetic centre: progress, results, and problems
J Med Genet
Prenatal diagnosis in 3000 women for chromosome, X-linked, and metabolic disorders
Am J Med Genet
Prenatal diagnosis of genetic disease in Canada: report of a collaborative study
Can Med Assoc J
Fetal chromosome analysis: screening for chromosome disease?
Prenat Diagn
Risks of midtrimester amniocentesis: assessment in 3000 pregnancies
Br J Obstet Gynecol
Midtrimester genetic amniocentesis in Eastern Ontario: a review from 1970–1985
J Med Genet
Genetic amniocentesis: a twelve years' experience
Am J Med Genet
A survey of diagnostic amniocentesis in Oxford for 1974–1981
Prenat Diagn
Prenatal diagnosis and outcome of pregnancy in 2036 women investigated by amniocentesis
Hum Genet
Prenatal genetic diagnosis in 3000 amniocenteses
N Engl J Med
Cited by (44)
New insights in congenital adrenal hyperplasia
2017, Annales d'EndocrinologieNew developments in prenatal diagnosis of congenital adrenal hyperplasia
2017, Journal of Steroid Biochemistry and Molecular BiologyThe consequences of implementing non-invasive prenatal testing in Dutch national health care: A cost-effectiveness analysis
2014, European Journal of Obstetrics and Gynecology and Reproductive BiologyCitation Excerpt :As invasive prenatal diagnosis is the gold standard for clinical decision-making these tests were modelled to be 100% sensitive and specific. Iatrogenic miscarriage rate was calculated by combining the miscarriage rates of chorionic villus sampling (0.5%) and amniocentesis (0.3%) with their share in the total number of invasive diagnostic procedures, 30% and 70%, respectively [15,16]. Assumptions were made regarding test uptake after the introduction of NIPT in Dutch health care, based on studies evaluating women's expressed interest in NIPT [28,29] and recent publications on actual choices made following the implementation of NIPT in prenatal care [30,31].
Perspectives of couples with high risk of transmitting genetic disorders
2010, Fertility and SterilityEthnic and socio-economic differences in uptake of prenatal diagnostic tests for Down's syndrome
2010, European Journal of Obstetrics and Gynecology and Reproductive BiologyCitation Excerpt :In the years 2000–2004, the period addressed in the present study, prenatal testing for Down's syndrome in The Netherlands consisted of reimbursed AMN and CVS. Both tests were offered to women aged 36 or above, because their age-related risk of carrying a child with Down's syndrome was considered sufficiently high to compensate for the risk of procedure-related fetal loss (0.3–0.8%) associated with invasive testing methods, such as AMN and CVS [12,13]. Non-invasive risk assessment tests, such as maternal serum screening and nuchal translucency measurement, were implemented in prenatal care after this study period.
Information about prenatal screening for Down syndrome. Ethnic differences in knowledge
2009, Patient Education and Counseling